Online adaptive radiotherapy using integrated vendor platforms: workflow timings using Radixact® and Raystation.
Samira Shire, United Kingdom | ESTRO | 2026
Development and implementation of online adaptive radiotherapy (oART) using a Radixact delivery platform in combination with the RayStation TPS
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
Hypofractionated preoperative radiotherapy in soft tissue sarcoma of the extremities andtrunk: outcomes from a prospective phase II study
Anastasia Stergioula | ESTRO | 2026
Optimizing Liver Dose Constraints in Total Marrow and Lymphoid Irradiation (TMLI) to Reduce the Risk of Veno-Occlusive Disease
Simonetta Saldi | ESTRO | 2026
Initial clinical experience of RayStation-based online adaptive RT using Radixact for endometrial cancer.
Irena Blasiak-Wal, United Kingdom | ESTRO | 2026
How low can we go? Margin validation of CT-based online adaptive radiotherapy (oART) in the post operative treatment of endometrial and cervix cancer
Benjamin J Thomas | ESTRO | 2026
Five-Fraction Whole- and Partial-Breast Irradiation Using Helical Tomotherapy: Comparative Dosimetry and Early Clinical Outcomes
Yu-Hsuan Chuang, Taiwan, Province of China | ESTRO | 2026
Automated DIBH breast radiotherapy using TomoDirect and VitalHold on a ring?based LINAC: feasibility, dosimetry and early tolerance
Paul RETIF, France | ESTRO | 2026
Evaluation of New SGRT-Based Approach to DIBH for Left-Sided Breast Cancers on a Helical Delivery Platform
Sanjay Hunugundmath et al. | ASTRO | 2025
Evaluation of Necessary and Sufficient PTV Margins for Offline Adaptive Head and Neck Cases Treated with TomoTherapy
Rose Kamal et al. | ASTRO | 2025
What is the Optimal Strategy for Re-Planning of Adaptive Radiotherapy of Head and Neck Cancer?
Hedda Enocson et al. | ASTRO | 2025
FLT-PET-Guided Dose-Escalated TMLI with Integrated Boost for AML: A Dosimetric Feasibility Study
Chunhui Han et al. | ASTRO | 2025
Esophageal Toxicity in Radical Radiotherapy Treatment of Malignant Pleural Mesothelioma
Alberto Revelant et al. | ASTRO | 2025
Lung-heart Toxicity in a Randomized Clinical Trial of Hypofractionated Image Guided Radiation Therapy for Breast Cancer
Van Parijs H, Cecilia-Joseph E, Gorobets O, Storme G, Adriaenssens N, Heyndrickx B, Verschraegen C, Nguyen NP, De Ridder M, Vinh-Hung V | Front Oncol. | 2025
Toxicity of Dose-escalated, Hypofractionated Helical TomoTherapy for Inoperable Thoracic Esophageal Squamous Cell Carcinoma
Zhang SM, Sun J, Pan XO, Zhu WC, Zhou YK | World J Clin Oncol | 2025
Long-term Cardiac Outcomes in Breast Cancer Patients Treated with Helical TomoTherapy: Evaluating the Applicability of 3D-based Dose Constraints for Intensity Modulated Radiation Therapy
Loap P, Uakkas A, Bouziane J, Fourquet A, Kirova Y | Int J Cancer | 2025
Long-term Outcomes of Salvage Radiotherapy Using TomoTherapy With Image-guided Radiotherapy for Postoperative Prostate Cancer Patients
Mukai Y, Omura M, Minagawa Y, Mase M, Nishikawa Y, Miura I, Hata M | Cancer Diagn Progn | 2025
Long-Term Results of Intensity Modulated Radiotherapy (IMRT) with Helical Tomotherapy in Non-Metastatic Breast Cancer Patients: Final Analysis
Loap P, Uakkas A, Allali S, Bouziane J, Fourquet A, Kirova Y | Cancers (Basel) | 2025
Improved Quality of Life in Head and Neck Cancer Patients Treated with Modern Arc Radiotherapy Techniques – A Prospective Longitudinal Analysis
Chuang EY, Hou PY, Shueng PW, Lo WC, Lin PY, Lin SC, Wu PH, Jiang JG, Chung CS, Hsu CX, Kuo DY, Lu YF, Liao LJ, Hsieh CH | Front Oncol | 2024
Surface Guided Ring Gantry Radiotherapy in Deep Inspiration Breath Hold for Breast Cancer Patients
Kadhim M, Haraldsson A, Kügele M, Enocson H, Bäck S, Ceberg S | J Appl Clin Med Phys | 2024
